Høeg LD, Sjøberg KA, Lundsgaard A-M, Jordy AB, Hiscock N, Wojtaszewski JFP, Richter EA, Kiens B. Adiponectin concentration is associated with muscle insulin sensitivity, AMPK phosphorylation, and ceramide content in skeletal muscles of men but not women. J Appl Physiol 114: 592-601, 2013. First published January 10, 2013; doi:10.1152/japplphysiol.01046.2012.-Adiponectin is an adipokine that regulates metabolism and increases insulin sensitivity. Mechanisms behind this insulin-sensitizing effect have been investigated in rodents, but little is known in humans, especially in skeletal muscle. Women have higher serum concentrations of adiponectin than men and are generally more insulin sensitive in skeletal muscle than men. We show here that large differences exist between men and women with regard to apparent adiponectin regulation of insulin-stimulated glucose uptake in skeletal muscle. Serum adiponectin was significantly associated with leg glucose uptake in healthy, young, lean men, but the association was absent in women. In addition, serum adiponectin was significantly associated with AMP-activated protein kinase (AMPK) phosphorylation in skeletal muscles of men but not in women. Serum adiponectin was also significantly, negatively associated with skeletal muscle ceramide content in men only, and interestingly, ceramide content was negatively associated with adiponectin receptor 1 (AdipoR1) expression in skeletal muscles of men. Women had lower AdipoR1 expression in skeletal muscle and a lower percentage of glycolytic adiponectin-sensitive type 2 muscle fibers than men. These associations suggest that the insulin-sensitizing effect of adiponectin on human male skeletal muscles may be mediated via AdipoR1 to activation of AMPK, leading to lowering of ceramide content. The lower skeletal muscle AdipoR1 protein expression and lower expression of adiponectin-sensitive type 2 muscle fibers in women than in men may explain the apparent lesser sensitivity to adiponectin in women.
ceramide; muscle; sex differences; AdipoR1; IMTG; metabolic flexibility ADIPONECTIN IS A HORMONE PRODUCED exclusively by adipocytes (30) . It has been suggested that adiponectin has insulin-sensitizing actions and that defects in adiponectin secretion or action play causal roles in the development of insulin resistance (4, 41) . Adiponectin consists of three domains, including a globular head domain, a signal sequence, and a collagen-like domain (2) . The adiponectin protein can undergo cleavage, leading to formation of a globular form of adiponectin containing only the globular head domain (11) . Globular adiponectin has been reported to account for ϳ1% of total circulating adiponectin (11) , and it is suggested that this fraction may be of biological significance (4) . Adiponectin exists in a wide range of multimer complexes in plasma and combines, via its collagen domain, to create three major oligomeric forms: low molecular weight trimers, middle molecular weight hexamers, and high molecular weight (HMW) complexes (20) . It has been reported in some (23) but not in all studies (27, 34) that HMW adiponectin is the most active form of the protein and plays the most relevant role for insulin sensitivity compared with the other multivalent forms of adiponectin. Nevertheless, all multimer forms of adiponectin correlated closely with total adiponectin concentrations in healthy, young, lean subjects, and especially, HMW adiponectin was highly associated with total adiponectin concentration (r ϭ 0.981) (8) . Thus total adiponectin is likely the best measure of biologically active adiponectin.
In obese and type 2 diabetic animal models, adiponectin levels were reduced (39) , and adiponectin knockout (KO) mice were found to be insulin resistant compared with wild-type (WT) mice in some studies (22, 25) but not in all (24) . Also, in glucose-intolerant obese and type 2 diabetic patients, low levels of circulating adiponectin were observed (1, 16, 41) , and an association between circulating adiponectin levels and whole-body insulin sensitivity was reported in obese and lean women (7, 38) and men (7, 12, 16, 38) at various ages (30 -65 years old) (7, 38) .
The mechanisms behind the insulin-sensitizing effect of adiponectin have been investigated in rodents, and findings suggested that globular and full-length adiponectin stimulated phosphorylation and activation of AMP-activated protein kinase (AMPK) (28, 40) . By blocking AMPK activation in C2C12 myocytes, using a catalytically inactive AMPK ␣2, which has a dominant-negative effect on both AMPK ␣1 and ␣2 activities in skeletal muscle, the improved insulin-sensitizing effect of administrated adiponectin was inhibited (40) . Findings in muscle strips from lean subjects incubated with globular adiponectin (4) , in L6 cells (5) , and in cultured myotubes from lean and obese glucose-tolerant and obese type 2 diabetic patients (6) showed increased fatty acid oxidation in skeletal muscle (4 -6) and increased AMPK phosphorylation (5) , although these effects were less in insulin-resistant type 2 diabetic patients (6) .
Recently, it was shown that adiponectin may increase the activity of mouse liver ceramidase, which is the enzyme that mediates the conversion of ceramide to sphingosine and thereby lowers the concentration of ceramide (18) . Since ac-cumulation of ceramide in skeletal muscle has been reported to be associated with impaired insulin sensitivity (32) , decreased ceramide concentration by adiponectin may be a mechanism for increasing insulin sensitivity in skeletal muscles. In addition, it has been suggested that adiponectin decreases insulin resistance by decreasing muscular lipid content in obese mice (41) .
Interestingly, women have higher serum concentrations of adiponectin than men (1, 7, 38) and generally, are more insulin sensitive in skeletal muscle than men (14, 15) , but whether these two observations are related is unknown. In humans, little is known about the effects of adiponectin on skeletal muscle metabolism and about the molecular mechanisms by which adiponectin stimulates glucose uptake. The aim of the present study was therefore to evaluate whether adiponectin could be used as a predictor for whole-body and skeletal muscle insulin sensitivity in healthy, young, lean men and women and to investigate whether mechanisms linked to the insulin-sensitizing effect of adiponectin, such as AMPK phosphorylation, and accumulation of lipid intermediates in skeletal muscle can be associated with levels of adiponectin in humans of either sex.
MATERIALS AND METHODS
Subjects. Men (n ϭ 23) and women (n ϭ 15) were recruited for the study after written, informed consent of study protocol and possible risks. The study was approved by the Copenhagen Ethics Committee (Number KF 01 261127) and performed in accordance with the Declaration of Helsinki II. All subjects were young, healthy, nonsmokers, and moderately fit. The men had a whole-body peak oxygen uptake (VO 2peak) of 52.5 Ϯ 0.6 ml O2·min
Ϫ1 ·kg body mass (BM) Ϫ1 , and the women had a VO2peak of 46.6 Ϯ 0.8 ml O2·min
Ϫ1 ·kg BM Ϫ1 (Table 1 ). All subjects participated on a regular basis (3-4 h/wk) in leisure-time physical activities. BM index (BMI) was in the range of 20 -25. Women were eumenorrheic, and none were taking oral contraceptives. All pre-experimental testing and the main experiments in women were performed in the midfollicular phase of their menstrual cycle (Days 7-11). Data on eight men and eight women were, in part, published previously in a study on intralipid-induced insulin resistance in women and men (15) . Data on the other 15 men and six women have not been published previously.
Pre-experimental testing. To determine VO 2peak, all subjects performed an incremental exercise test on a Monark Ergomedic 839E bicycle ergometer (Monark, Varberg, Sweden). In addition, they filled out a questionnaire regarding habitual physical activity and exercise training. Lean BM (LBM) and lean leg mass (LLM) were calculated from their body composition, determined by dual-energy X-ray absorptiometry (DPX-IQ; Lunar, Madison, WI). The determination of body composition was carried out after a 4-h fasting period, where subjects refrained from all food and liquids. Men and women were matched with respect to VO 2peak, expressed relative to LBM, habitual physical activity level, and exercise training history (Table 1) .
Diet. For 8 days preceding the main trial, all subjects consumed an isoenergetic diet containing 60 energy percent (E%) carbohydrate, 25 E% fat, and 15 E% protein. The constituents of the diet were weighed at the laboratory and given to the subjects. The amount of energy to be consumed was determined individually from body weight, sex, and habitual physical activity level based on guidelines from the World Health Organization. Subjects kept their body weight steady during the dietary regimen.
Experimental protocol. The subjects arrived at the laboratory at 7 AM after consuming a light breakfast (20% of the daily energy intake) at 5 AM, 3 h before the experiment started. Subjects had abstained from exercise training 48 h before the experimental day. After 45 min of rest in a supine position, expired air was collected in Douglas bags for determination of respiratory exchange ratio (RER). A venous catheter was inserted into an antecubital arm vein, and blood was drawn for determination of adipokines and cytokines. Teflon catheters were then inserted into the femoral artery and vein of one leg. Then, subjects underwent a 120-min hyperinsulinemic-euglycemic clamp (1.42 mU·kg BM Ϫ1 ·min Ϫ1 of insulin), initiated with a bolus injection of insulin (9.0 mU/kg; Actrapid; Novo Nordisk, Bagsvaerd, Denmark). To determine leg glucose uptake, blood was sampled simultaneously from the femoral artery and vein, and femoral venous blood flow was determined by the thermodilution method (29) every 20 min during the clamp. Expired air was sampled in Douglas bags before, during, and at the end of the clamp.
Biopsies were obtained from the vastus lateralis muscle prior to the clamp and at the end of the clamp. One part of the muscle biopsy was frozen immediately in liquid nitrogen and stored at Ϫ80°C. Another part of the muscle biopsy was mounted in embedding medium, frozen in precooled isopentane, and stored at Ϫ80°C. Before biochemical analysis, muscle tissue (ϳ80 mg wet weight) was freeze dried and dissected free of all visible adipose tissue, connective tissue, and blood under a microscope. The dissected muscle fibers were pooled and then divided into subpools for the respective analyses.
Analysis
Breath samples. Expired volumes of air in the Douglas bags were measured with a chain-suspended Collins spirometer, and expiratory air was analyzed for O2 (S-3A; Servomex, Crowborough, UK) and CO 2 (LB2; Beckman Coulter, Irvine, CA). RER was calculated as the ratio between pulmonary CO2 excretion and O2 uptake.
Blood and plasma metabolites. Blood glucose concentration was measured on an ABL 615 (Radiometer Medical, Brønshøj, Denmark). Plasma glycerol (Beckman Coulter, County Clare, Ireland) and plasma triacylglycerol (TG; GPO-PAP kit) concentrations were measured using enzymatic colorimetric methods (Hitachi 912 automatic analyzer; Boehringer Mannheim, Indianapolis, IN). Plasma TG concentration was calculated as plasma TG minus free plasma glycerol. Whole cell lysate preparation. Freeze-dried and dissected muscle tissue was homogenized as described previously (37) . Homogenates were rotated end over end for 1 h at 4°C and then cleared by centrifugation for 20 min (16,000 g, 4°C).
Western blotting. Protein content in muscle lysates was determined in triplicate using the bicinchoninic acid (BCA) method using BSA standards (Pierce, Rockford, IL) and BCA assay reagents (Pierce). A maximal coefficient of variance of 5% was accepted between replicates. All samples were heated (96°C) in Laemmli buffer before being subjected to SDS-PAGE and immunoblotting. Total protein and phosphorylation levels of relevant proteins were determined by standard immunoblotting techniques. Muscle lysate proteins were separated by SDS-PAGE and Western blotting, followed by immunodetection, as described previously (10) . The primary antibodies used for detection of total protein levels were anti-AMPK ␣2 antibody (kindly donated by Dr. Grahame Hardie, University of Dundee, Dundee, Scotland), anti-Akt 2 (Upstate Biotechnology, Lake Placid, NY), anti-adiponectin receptor 1 (AdipoR1; Abcam, Cambridge, UK), and anti-actin (Sigma-Aldrich, St. Louis, MO). The primary phosphospecific antibodies used were anti-phospho AMPK Thr 172 (Cell Signaling Technology, Danvers, MA), anti-phospho Akt Ser 473 (Cell Signaling Technology), and anti-phospho Akt Thr 308 (Upstate Biotechnology).
Skeletal muscle ceramide and diacylglycerol (DAG) were extracted in chloroform:methanol (2:1, v/v) from freeze-dried and dissected muscle tissue (9) and separated by thin-layer chromatography. Lipid bands were developed at 120°C in 15 min and visualized and quantified by a Kodak Image Station E440 CF (Kodak, Glostrup, Denmark).
Intramuscular triacylglycerol (IMTG) was determined by biochemical methods on freeze-dried and dissected tissue as described previously (21) .
ATPase staining. Serial cross-sections (10 m) were cut and stained for myofibrillar ATPase to identify types 1, 2A, and 2X muscle fibers (3). Muscle fiber-type composition was analyzed in all subjects by the same blinded observer using TEMA image analysis software (CheckVision, Støvring, Denmark).
Calculations
Insulin sensitivity on a whole-body level was expressed as area under the curve (AUC) of the glucose infusion rate (GIR) during the last 30 min of the hyperinsulinemic euglycemic clamp. Insulinstimulated leg glucose uptake was calculated as the arterial-venous blood glucose concentration difference times blood flow (Fick's principle) during the hyperinsulinemic euglycemic clamp. Insulinstimulated leg glucose uptake was expressed as AUC during the last 30 min of the hyperinsulinmic euglycemic clamp minus the basal individual level prior to the hyperinsulinemic euglycemic clamp (AUC).
Statistics. All data are expressed as means Ϯ SE. Data were evaluated using two-way ANOVA with repeated measures for time and sex. For variables independent of time, one-way ANOVA was used to determine influences of sex. A Holm-Sidak test was used as a post hoc test. Correlation was investigated using the Pearson product moment correlation. A significance level of P Ͻ 0.05 was chosen. The data were tested for outliers using the Grubb's statistical test. Since no outliers were found using this test (with a significance level of 0.05), no values from the dataset were removed.
RESULTS
Muscle morphology. The percentage of type 1 fibers was lower in men than in women (P Ͻ 0.05), and percentage of type 2 fibers was higher in men than in women (P Ͻ 0.05; Table 1 ).
Blood flow, blood, and plasma parameters. Preclamp leg blood flow was similar in men and women and was increased with insulin infusion (P Ͻ 0.05) in both sexes (Table 2 ). Blood arterial glucose concentration was 5.5 Ϯ 0.1 and 5.4 Ϯ 0.1 mM in men and women, respectively, and remained stable throughout the hyperinsulinemic euglycemic clamp period. Plasma insulin concentration was similar in men and women preclamp and increased in response to insulin infusion to similar levels in both men and women (Table 2) .
Adipokines and cytokines. Serum adiponectin concentration was lower (P Ͻ 0.05) in men than in women before the hyperinsulinemic euglycemic clamp ( Table 2 ). Serum TNF-␣ concentration was not different between sexes (Table 2 ). There was a positive correlation between serum adiponectin and TNF-␣ concentration in women but not in men and not when sexes were analyzed together (Table 3) .
RER and metabolic flexibility. RER preclamp was not different between sexes and increased (P Ͻ 0.05) to a similar level in both men and women during the hyperinsulinemic euglycemic clamp (Table 2) . We observed a borderline negative association between serum adiponectin concentration and resting RER levels in men and women analyzed together and in men (Table 3 ). This association was not observed in women alone ( Table 3) .
The metabolic flexibility (⌬ RER) was similar in men and women (Table 2) . Adiponectin concentration was associated with metabolic flexibility (⌬ RER) in men and women when analyzed together. When sexes were analyzed separately, there was a tendency toward an association in men (P ϭ 0.07) but not in women (Table 3) . (Fig. 2) , confirming our previous findings (14) . Surprisingly, serum adiponectin and whole-body GIR did not correlate in these healthy subjects. However, serum adiponectin concentration correlated significantly with insulin-stimulated leg glucose uptake in men and women when analyzed together (Fig. 1B) . When sexes were analyzed separately, a significant correlation was observed in men (Fig. 1C) but not in the women (Fig. 1D) .
AMPK phosphorylation in skeletal muscle. AMPK Thr 172 phosphorylation was not different between the preclamp of sexes and remained unchanged during the clamp in either sex (Fig. 3A) . Serum adiponectin concentration was correlated significantly with skeletal muscle AMPK Thr 172 phosphorylation levels (Fig. 3B) . The correlation was even stronger in men (Fig. 3C ) and not present in women when data were analyzed separately (Fig. 3D) .
Lipid intermediates and IMTG. Skeletal muscle DAG content was not different in men and women at basal and was not changed with insulin infusion (Table 2 ). IMTG concentration preclamp was 41% lower in men than in women and remained unchanged during the clamp (Table 2 ). There was no correlation between adiponectin concentration and skeletal muscle DAG content in either men or women (data not shown). There was a significant, positive association between adiponectin levels and IMTG concentration when including all subjects, but this association was not observed in men or in women alone (Table 3) . Ceramide content in vastus lateralis muscle preclamp was 39 Ϯ 7 and 46 Ϯ 5 AU dry weight in men and women, respectively (Fig. 4A ). There was a significant negative correlation between serum adiponectin and skeletal muscle Fig. 1 . Insulin-stimulated leg glucose in men and women and correlations between serum adiponectin and insulin-stimulated leg glucose uptake in men and women analyzed separately and together. A: insulin-stimulated leg glucose uptake in men (black bar) and women (white bar). *P Ͻ 0.05 compared with men. B: the correlation between serum adiponectin and insulin-stimulated leg glucose in both men (black dots) and women (white dots); n ϭ 38. C: the correlation between serum adiponectin and insulin-stimulated leg glucose in men; n ϭ 23. D: the correlation between serum adiponectin and insulin-stimulated leg glucose in women; n ϭ 15. LLM, lean leg mass.
ceramide content in men alone (Fig. 4C) but not in women alone (Fig. 4D) and not when all subjects were analyzed together (Fig. 4A) . AdipoR1. Skeletal muscle AdipoR1 was higher in men compared with women preclamp and was not changed with insulin infusion (Fig. 5A) . Interestingly, skeletal muscle AdipoR1 correlated negatively with skeletal muscle ceramide content in men only (Fig. 5C ) but not in women and not in all subjects analyzed together (Fig. 5, B and D) .
Plasma arterial TG concentration was slightly higher in men (769 Ϯ 63 mol/l) compared with women (550 Ϯ 29 mol/l) preclamp and was decreased similarly with insulin infusion in both sexes (Fig. 6A) . Serum adiponectin concentration was negatively correlated with basal plasma arterial TG concentrations (Fig. 6A) . When women and men were analyzed separately, serum adiponectin concentration was significantly, negatively associated with plasma TG concentration in men only (Fig. 6C) but not in women (Fig. 6D) .
Serum adiponectin correlated negatively with BMI and positively with fat percentage when all subjects were analyzed together but not when sexes were analyzed separately. Fat mass per se did not correlate with serum adiponectin (Table 3) .
DISCUSSION
The present study demonstrates large differences between men and women with regard to apparent adiponectin regulation of insulin-stimulated glucose uptake in skeletal muscle. Thus serum adiponectin concentration was associated with skeletal muscle insulin-stimulated glucose uptake only in healthy, young, lean men but not in healthy, young, lean women when measurements were obtained in the midfollicular phase of the menstrual cycle in women. In addition, an association between serum adiponectin and skeletal muscle AMPK Thr 172 phosphorylation was observed in men alone but not in women. Furthermore, an inverse correlation between serum adiponectin and skeletal muscle ceramide content was apparent only in men, and interestingly, ceramide content was also negatively associated with AdipoR1 expression in skeletal muscles of men, whereas these associations were absent in women. We interpret these data to mean that men and women have different sensitivity for adiponectin in skeletal muscles when measured in the midfollicular phase of the menstrual cycle in women. The beneficial effects of adiponectin on glucose metabolism in skeletal muscles of men may be ascribed to AMPK phosphorylation and ceramide content in skeletal muscles.
Associations between serum adiponectin and whole-body insulin sensitivity in both men and women at various ages (30 -65 years old) and body weight (7, 38) were reported previously when whole-body insulin sensitivity was assessed by insulin index with a minimal model of glucose kinetics (7) or homeostatic model assessment (38) . In healthy, young, lean subjects alone, we were not able to find a significant association between whole-body insulin sensitivity and serum adiponectin levels in the present study in men or women. However, this association was apparent when insulin sensitivity was measured as insulin stimulated glucose uptake across the leg. Interestingly, when the sexes were analyzed separately, the association was only significant in men and not women (Fig. 1,  C and D) . Why the association was significant in men and not in women when the two sexes were analyzed separately is not readily apparent. However, as found by others (1, 7), we also found that women have considerably higher concentrations of adiponectin than men and perhaps, as a consequence, have a downregulation of AdipoR number in skeletal muscle (Fig.  5A) . Coupled with the markedly higher plasma adiponectin concentration in women than in men, this may result in adiponectin desensitization in women requiring larger variations in adiponectin than observed in this sample of women to result in physiological changes in target tissues. On the other hand, one may expect that the higher adiponectin concentration may compensate for the lower AdipoR protein content in women; however, this seems not to be the case. The effect of adiponectin on skeletal muscle insulin sensitivity in women seems to be limited by the lower expression of AdipoR1 in women com- phosphorylation/AMPK ␣2 total protein expression in men and women in the basal (black bars) and insulin-stimulated state (gray bars). B: the correlation between serum adiponectin and AMPK Thr 172 phosphorylation/AMPK ␣2 total protein expression in the insulin-stimulated state in both men (black dots) and women (white dots); n ϭ 38. C: the correlation between serum adiponectin and AMPK Thr 172 phosphorylation/AMPK ␣2 total protein expression in the insulin-stimulated state in men; n ϭ 23. D: the correlation between serum adiponectin and AMPK Thr 172 phosphorylation/ AMPK ␣2 total protein expression in the insulin-stimulated state in women; n ϭ 15. Fig. 4 . Ceramide content in the vastus lateralis muscle in men and women and the correlations between serum adiponectin and skeletal muscle ceramide content in men and women analyzed separately and together. A: ceramide content in men (black bar) and women (white bar) in the basal state. B: the correlation between serum adiponectin and ceramide content in the basal state in both men (black dots) and women (white dots); n ϭ 32. C: the correlation between serum adiponectin and ceramide content in the basal state in men; n ϭ 20. D: the correlation between serum adiponectin and ceramide content in the basal state in women; n ϭ 12.
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Serum Adiponectin Concentrations and Insulin Stimulated Leg Glucose Uptake in Men and Women • Høeg LD et al. pared with men. It was recently shown that AdipoR1 KO mice have a significantly decreased glucose disposal rate and GIR during a hyperinsulinemic euglycemic clamp but similar endogenous glucose production as WT controls, indicating decreased insulin sensitivity in peripheral tissues (19) . Furthermore, overexpression of AdipoR1 in rat skeletal muscle amplifies insulin-stimulated glucose uptake into skeletal muscle (28) . These findings support that the lower level of AdipoR1 protein expression in women may explain the apparent lack of physiological effects of adiponectin on insulin-stimulated glucose uptake in skeletal muscle of women.
Another factor that could explain the sex difference is that it has been shown that incubation of extensor digitorum longus (EDL) and soleus rat muscle with globular adiponectin caused increased AMPK activity only in glycolytic type 2 fibers (EDL) (33) . If adiponectin only promotes AMPK phosphorylation in type 2 fibers, this could be one reason why an association between adiponectin and AMPK phosphorylation was observed only in men and not in women, because men expressed 42% more type 2 fibers than women (Table 1) . Finally, it should be noted that in the present investigation, women were studied in the midfollicular phase of the menstrual cycle.
Our findings in men suggest that adiponectin plays a modulating role of human skeletal muscle insulin sensitivity via activation of AMPK. Others (41) have described that adiponectin decreased insulin resistance by decreasing muscular lipid content in obese mice. An accumulation of lipid intermediates, such as ceramide and DAG, has been linked to impaired insulin sensitivity in rodent studies (17, 42) . Also, IMTG content has been reported to be associated with impaired insulin sensitivity in obese and type 2 diabetics (13, 31) . However, we (14) and others (13) have shown that IMTG content per se is not related to insulin sensitivity in healthy, young, normal weight subjects. In line with this notion, we observed no correlation between serum adiponectin concentration and IMTG content or between serum adiponectin concentration and DAG content when sexes were analyzed separately. These data were supported by previous findings showing unaffected DAG and IMTG content by globular adiponectin treatment, despite the observed increase in fatty acid oxidation in isolated muscle strips from lean and obese women (4) and in rats (26) .
It was shown previously that adiponectin via its receptors, AdipoR1 and AdipoR2, can regulate glucose and fatty acid metabolism partly via activation of AMPK in liver (39) and muscles (35) of mice. In a recent study, it was demonstrated that ceramide signaling is a new player involved in mediating the pleiotropic effects of adiponectin in mice (18) , as it was demonstrated that adiponectin lowers liver ceramide levels in mice via activation of ceramidase, which converts ceramide to sphingosine (18) . In that study, overexpression of AdipoR1 and AdipoR2 in liver reduced hepatic ceramide levels and improved insulin sensitivity, and deficiency of adiponectin increased hepatic ceramide levels and exacerbated insulin resistance (18) , suggesting that this conversion of ceramide to sphingosine was dependent on activation of AdipoR1 and AdipoR2 in liver. Whether this scenario also operates in skeletal muscles is suggested by our findings that skeletal muscle AdipoR1 protein expression correlated significantly with skeletal muscle ceramide content in men (Fig. 5B) and that plasma adiponectin correlated inversely with skeletal muscle ceramide content (Fig. 4B) .
Collectively, these associations suggest that the beneficial effects of adiponectin on glucose metabolism in skeletal muscle of men may be ascribed to AMPK phosphorylation and ceramide content in skeletal muscle. However, although the correlations are significant, they are not strong, with r values ϳ0.4 -0.5, meaning that only ϳ20% of the variability can be explained by variability in serum adiponectin concentrations. The relatively low magnitude of the correlations is likely due to the homogeneity of the studied subjects. It is possible that the magnitude of the associations would have been more pronounced in a group with broader variation of subject characteristics. However, we believe that a significant correlation in a uniform group provides a strong evidence of an association and that these significant associations, therefore, may be of biological importance.
In the present study, total serum adiponectin was used in the correlations with metabolic parameters. It is possible that the association may improve if the HMW form of adiponectin were used in the correlation, since some studies have suggested that the HMW form of adiponectin is the most relevant regarding whole-body insulin sensitivity, as reviewed by Kadowaki et al. (20) . This is primarily based on findings from subjects with rare mutations in the collagen domain that were associated with type 2 diabetes (36). These subjects expressed low levels of HMW adiponectin concentrations (20) . Furthermore, it was found that the ratio of plasma HMW adiponectin levels to total adiponectin levels correlated with whole-body glucose disposal measured by hyperinsulinemic euglycemic clamp in 68 women and men with and without type 2 diabetes (23). On the other hand, it was suggested that HMW adiponectin was important for hepatic glucose production and not skeletal muscle insulin sensitivity, because an increased ratio of plasma HMW adiponectin levels to total adiponectin levels correlated with improvement in hepatic insulin action only but not with insulin-stimulated glucose uptake in peripheral tissue during treatment with an insulin-sensitizing drug, thiazolidinedione, in type 2 diabetic patients (27, 34) . Since no consensus on the role of HMW adiponectin in skeletal muscles exists from the literature, total adiponectin concentrations were used in the attempt to better understand the role of this hormone in skeletal muscles. At any rate, all multimere forms of adiponectin correlated with total adiponectin concentrations in healthy, young, lean subjects, and HMW adiponectin was highly associated with total adiponectin concentration in healthy, young, lean men and women (r ϭ 0.981) (8) . Therefore, it seems that total adiponectin provides the best measure of biologically active adiponectin.
In conclusion, the present study demonstrates that a sex difference exists in the association between serum adiponectin concentration and insulin-stimulated leg glucose uptake, as well as adiponectin metabolic targets in skeletal muscle. The association between serum adiponectin concentration and insulin-stimulated leg glucose uptake was only apparent in healthy, young, lean men and not in healthy, young, lean women when sexes were analyzed separately. Likewise, associations between serum adiponectin and skeletal muscle Fig. 6 . Plasma triacylglycerol (TG) concentration in men and women and the correlations between serum adiponectin concentration and plasma TG concentration in men and women analyzed separately and all together. A: plasma TG concentration in men (black bar) and women (white bar) in the basal state. *P Ͻ 0.05 compared with men. B: the correlation between serum adiponectin concentration and plasma TG concentration in the basal state in both men (black dots) and women (white dots); n ϭ 38. C: the correlation between serum adiponectin concentration and plasma TG concentration in the basal state in men; n ϭ 23. D: the correlation between serum adiponectin concentration and plasma TG concentration in the basal state in women; n ϭ 15.
AMPK phosphorylation and negative associations between adiponectin and skeletal muscle ceramide content were observed in men but not in women. These findings suggest that adiponectin-induced AMPK activation causes decreased skeletal muscle ceramide levels, in turn, increasing insulin sensitivity in men. The higher serum adiponectin concentration combined with lower skeletal muscle AdipoR1 protein expression and lower expression of adiponectin-sensitive type 2 muscle fibers in women than in men may explain the smaller effect on the measured adiponectin-stimulated targets in women.
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